AHRP Letter to the editor re: editorial ARDS trial July 10, 2003. The New England Journal of Medicine. Volume 349:188-192 Number 2 http://content.nejm.org/cgi/content/extract/349/2/188 Note: The April 3, 2003 the NEJM contained an editorial in support of a controversial multi-site, clinical trial sponsored by the National Heart, Lung, and Blood Institute…
Hopkins Asks Patients to Waive Privacy Rights to Facilitate Research Recruiting – AP/ ABC Tue, 8 Jul 2003 In the 19th century doctors robbed graves to obtain cadavers for medical training purposes. Today, medical researchers are far more ambitious– they seek backdoor access to living patients for medical experiments. A…
New Jersey Foster Children Lingering in Mental Wards Mon, 30 Jun 2003 The New York Times reports that foster children in New Jersey are being dumped in locked psychiatric hospital wards for lack of facilities to which to send them. More than 300 children, ages 6 to 17, many in…
On June 10, 2003, a panel of experts convened by the federal Office of Human Research Protections (OHRP) heard presentations by critics who had filed complaints about $37 million government sponsored, multi-site experiment conducted by major academic institutions participating in the ARDSNetwork, and by the ARDSNet investigators who defend the trial.
The experiment tested two extreme, rarely used methods of mechanical lung ventilation in 861 critically ill, vulnerable patients suffering from acute lung disease (ALD) or acute respiratory distress syndrome (ARDS).
Once Misdiagnosed, Writer Teaches Psychiatrists About Treatment – Psychol Today Fri, 27 Jun 2003 An article in Psychology Today is about an incredible story of survival. A teenager misdiagnosed with schizophrenia, then wrongly incarcerated in a psychiatric hospital. Mindy Lewis survived for three years of being “drugged and locked away…
Rate of Preschool Kids Prescribed Antidepressants Skyrockets – Cong Investigates FDA Fri, 2 Apr 2004 A new survey by Express Scripts found the rate at which American children are prescribed antidepressants almost doubled (49%) in 5 years. The steepest unfathomable, medically unsupportable, increase–64%–was among preschool children. This is evidence of…
ACNP – a pharmaceutical industry funded association of psychiatrists – claims SSRI Antidepressants don’t increase suicidal behavior Wed, 21 Jan 2004 related links: Reply to ACNP Report – Jonathan Leo, Ph.D. FDA Sham Conflicts of Interest Policy The American College of Neuropsychopharmacologists (ACNP), an organization of psychiatrists with significant financial…
June 18, 2003. GlaxoSmithKline, manufacturer of Paroxetine (Seroxat, Paxil) issued a letter addressed to British Healthcare Professionals, disclosing that the drug was found be linked to serious undesirable effects in depressed children and adolescents under age 18. Below is an excerpt followed by the original letters: UNDESIRABLE EFFECTS Adverse events…
Supreme Court Halts Forced Drugging – AAPS Press Release Mon, 16 Jun 2003 The Supreme Court rules against government efforts to force citizens to take mind-altering psychotropic drugs against their will. The 6 to 3 Supreme Court decision overturned lower district and appellate courts in the case of Dr. Charles…
Toxicologist Blames Prozac for Wife’s Suicide – UK Fri, 27 Jun 2003 News reports from the UK are awash with cases of drug-induced violent suicidal behavior by patients taking Prozac, Paxil and the other antidepressant drugs in their class–i.e., selective serotonin reuptake inhibitors. A coroner’s inquest of the suicide by…
New AJOB InFocus article Examines Children in Clinical Research For immediate release May 7, 2003 (Philadelphia, PA) — The comprehensive study by Vera Hassner Sharav, President, The Alliance for Human Research Protection, examines a wide range of clinical research trials conducted on children and the ethical conflicts that arise from…
Rehnquist Warns Drug Makers _Marketing Actimune for Unapproved Use_NYT Mon, 28 Apr 2003 1. The New York Times reports that Janet Rehnquist, the Inspector General of the Department of Health and Human Services, has issued “a compliance guide for drug manufacturers” in which they are waned that many of their…
